Yield10 Bioscience, Inc. (YTEN) Misses Q1 EPS by 5c, Revenues Miss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Yield10 Bioscience, Inc. (YTEN) Misses Q1 EPS by 5c, Revenues Miss

Yield10 Bioscience Announces First Quarter 2021 Financial Results

May 11, 2021 4:05 PM EDT

WOBURN, Mass., May 11, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today reported financial results for the three months ended March 31, 2021.

"We remain solidly on track for progressing our technical and business plans to support a specialty products business based on our Camelina platform," said Oliver Peoples, Ph.D., president and chief executive officer of Yield10 Bioscience. "During 2021, we will scale-up seed production of certain new Camelina varieties as well as evaluate our novel yield traits in multi-site field trials conducted in the U.S.... More